Biofilm-associated multi-drug resistance in hospital-acquired infections: A review

M Assefa, A Amare - Infection and drug resistance, 2022 - Taylor & Francis
Biofilm-related multi-drug resistance (MDR) is a major problem in hospital-acquired
infections (HAIs) that increase patient morbidity and mortality rates and economic burdens …

TiO2 Nanocomposite Coatings and Inactivation of Carbapenemase-Producing Klebsiella Pneumoniae Biofilm—Opportunities and Challenges

AS Bereanu, BI Vintilă, R Bereanu, IR Codru… - Microorganisms, 2024 - mdpi.com
The worldwide increase of multidrug-resistant Gram-negative bacteria is a global threat. The
emergence and global spread of Klebsiella pneumoniae carbapenemase-(KPC-) producing …

ESKAPE bacteria characterization reveals the presence of Acinetobacter baumannii and Pseudomonas aeruginosa outbreaks in COVID-19/VAP patients

MÁ Loyola-Cruz, EM Durán-Manuel… - American journal of …, 2023 - Elsevier
Introduction A decrease of detection of outbreaks by multidrug-resistant bacteria in critical
areas has been reduced due to COVID-19 pandemic. Therefore, molecular epidemiological …

Fresh produce as a potential vehicle for transmission of Acinetobacter baumannii

Q Ababneh, E Al-Rousan, Z Jaradat - International Journal of Food …, 2022 - Springer
Acinetobacter baumannii is a Gram-negative bacterium that has gained a stronghold inside
healthcare settings. Due to the ability of A. baumannii to acquire antibiotic resistance easily …

Prevalence, genetic diversity, antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from urban environments

Q Ababneh, S Abu Laila… - Journal of Applied …, 2022 - academic.oup.com
Aim Acinetobacter baumannii is a well‐known nosocomial pathogen that has been isolated
from different clinical sources. This pathogen also causes community‐acquired infections …

Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of Acinetobacter baumannii from the Largest Department of Internal Medicine …

Y Jalali, A Liptáková, M Jalali, J Payer - Antibiotics, 2023 - mdpi.com
A. baumannii imposes a great burden on medical systems worldwide. Surveillance of trends
of antibiotic resistance provides a great deal of information needed for antimicrobial …

Evaluation of CHROMagar Acinetobacter and MacConkey media for the recovery of Acinetobacter baumannii from soil samples

I Yusuf, E Skiebe, G Wilharm - Letters in Applied Microbiology, 2023 - academic.oup.com
The opportunistic pathogen Acinetobacter baumannii occupies niches in human and
veterinary clinics and other environments. This comparative study was designed to assess …

Extensive Drug Resistance of Strong Biofilm-Producing Acinetobacter baumannii Strains Isolated from Infections and Colonization Hospitalized Patients in Southern …

T Kasperski, D Romaniszyn, E Jachowicz-Matczak… - Pathogens, 2023 - mdpi.com
Acinetobacter baumannii (AB) is a bacterium that causes infections, particularly in
immunocompromised patients. Treatment is challenging due to biofilm formation by AB …

Massive sequencing of the V3–V4 hypervariable region of bronchoalveolar lavage from patients with COVID-19 and VAP reveals the collapse of the pulmonary …

EM Durán-Manuel, MÁ Loyola-Cruz… - Journal of Medical …, 2022 - microbiologyresearch.org
Background. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic is a predisposing factor for the development of healthcare-associated infections …

Nosocomial surveillance of multidrug-resistant Acinetobacter baumannii: a genomic epidemiological study

Z Duan, X Li, S Li, H Zhou, L Hu, H Xia… - Microbiology …, 2024 - Am Soc Microbiol
Acinetobacter baumannii is a major opportunistic pathogen causing hospital-acquired
infections, and it is imperative to comprehend its evolutionary and epidemiological dynamics …